Matches in Nanopublications for { ?s ?p "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP661603.RAnUBvydHfdNDIrREi_hVStE2UxeEglhk7WggMu4sX0oE130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661603.RAnUBvydHfdNDIrREi_hVStE2UxeEglhk7WggMu4sX0oE130_provenance.
- NP601406.RAb37lbzkZtl3YLwroTGf7Tl3btM_jooW4BRF0KRoiV20130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601406.RAb37lbzkZtl3YLwroTGf7Tl3btM_jooW4BRF0KRoiV20130_provenance.
- NP811871.RAYoVmYxj35TZtyyt97tBTjFPvIL_o12c16YUr6RDm9YE130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811871.RAYoVmYxj35TZtyyt97tBTjFPvIL_o12c16YUr6RDm9YE130_provenance.
- NP262376.RAuW5KJmOonTv0Do_PBGgmDvCevx_e9L4QH243XVfcCSM130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262376.RAuW5KJmOonTv0Do_PBGgmDvCevx_e9L4QH243XVfcCSM130_provenance.
- assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP827024.RAsW-0gkGeiZIv-zBcW_j0PDmg0EhKQhNibTS2t0LoHWg130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827024.RAsW-0gkGeiZIv-zBcW_j0PDmg0EhKQhNibTS2t0LoHWg130_provenance.
- assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_provenance.
- NP442248.RAJB6DayIQZNd9UCUOxJyKJYasqoDaZV0H5Lb19U-atQE130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442248.RAJB6DayIQZNd9UCUOxJyKJYasqoDaZV0H5Lb19U-atQE130_provenance.
- NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566952.RALbCmbcYoCbBLQiuYfqJ_L9PNY6KWXzrcvJohoNbWcyg130_provenance.
- NP566955.RAPtR3HLXuLXoOUC5NTpHSwDR8qssI4D8Ju3pe_1ZYOJg130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566955.RAPtR3HLXuLXoOUC5NTpHSwDR8qssI4D8Ju3pe_1ZYOJg130_provenance.